-
February 26: The Week in Cancer News
Nonprofits provide support to young cancer patients in need of fertility preservation, and a childhood cancer survivor joins the first all-civilian mission to space.
by Bradley Jones
-
Patient Advocates Tune in for Precision Medicine Primer
Scientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers.
by Kevin McLaughlin
-
Immunotherapy Options for Breast Cancer
Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.
by Anna Goshua
-
Colorectal Cancer Screenings at Home
Stool-based tests could increase access to colorectal cancer screening.
by Jen Tota McGivney
-
January 8: The Week in Cancer News
Two extremely rare cases of cancer being passed from mother to child observed in Japan, and advice on COVID-19 vaccines for cancer patients.
by Bradley Jones
-
From the Editor-in-Chief
Intercepting Cancer by Tackling PrecancerResearch on premalignancy is needed to fully tap the potential of cancer interception.
by William G. Nelson, MD, PhD
-
Are Liquid Biopsies Ready for the Clinic?
Sophisticated blood tests offer a less invasive way to characterize cancers, guide treatment and catch recurrences sooner, but tissue biopsies remain the gold standard.
by Kendall K. Morgan
-
Forward Look
Scanning DisparitiesWhether lung cancer patients receive PET scans depends on race, according to a study.
by Ashley P. Taylor
-
Healthy Habits
Health NutsEating tree nuts may decrease cancer risk, especially for cancers of the digestive system.
by Tara Santora
-
Forward Look
Doing More With LessHypofractionation may allow patients to finish radiation treatment sooner.
by Stephen Ornes
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles